Turgeon, D K <br/><br/>
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.  [electronic resource] 

 -  Transplantation  Jun 1994 
 - 1736-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Breath Tests<br/>Cyclosporine<br/>Cyclosporins--blood<br/>Dose-Response Relationship, Drug<br/>Erythromycin<br/>Female<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Diseases--surgery<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Patient Compliance<br/>Predictive Value of Tests<br/>Regression Analysis